Gold vs US Dollar

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Aclaris Therapeutics Inc (ACRS)
Aclaris Therapeutics Inc (ACRS) Financials

ACRS Aclaris Therapeutics Inc

4.21

0.25 (6.31%)

Last Updated: 19:31:55

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-35.593	-32.662	-51.144	-86.317	-60.344	-56.439	-34.364	-39.151
Return on Equity (%)	-36.7	-34.717	-60.283	-113.217	-94.857	-77.335	-44.008	-49.877
Return on Invested Capital (%)	-44.604	-40.892	-59.287	-58.801	-86.341	-61.934	-48.853	-83.976
Operating Margin (%)	N/A	-4180.214	-1315.41	-2686.113	-791.978	-1343.958	-292.108	-284.323
Net Profit Margin (%)	N/A	-4071.48	-1315.41	-3817.223	-787.026	-1343.958	-292.108	-283.148
Book Value Per Share	6.504	6.463	3.001	1.512	0.677	3.108	2.859	2.215
Earnings Per Share	-1.845	-2.221	-3.221	-3.889	-1.131	-1.484	-1.303	-1.249
Cash Per Share	1.158	0.655	1.384	0.866	0.489	0.447	0.679	0.563
Working Capital Per Share	5.078	6.075	3.692	1.479	0.945	2.974	3.143	1.382
Operating Profit Per Share	N/A	0.028	0.124	0.042	0.059	0.049	0.398	0.405
EBIT Per Share	-1.845	-2.28	-3.221	-2.737	-1.138	-1.484	-1.303	-1.254
EBITDA Per Share	-1.845	-2.28	-3.221	-2.737	-1.138	-1.484	-1.303	-1.254
Free Cash Flow Per Share	-1.841	-2.194	-1.605	-3.889	-1.15	-1.494	-1.306	-1.243

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	26.06M	30.86M	41.21M	41.49M	45.11M	61.23M	66.69M	N/A

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	N/A	66.69M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	-1113.924	N/A	N/A	N/A	-706.464	N/A
Net Profit Margin (%)	N/A	N/A	-1113.924	N/A	N/A	N/A	-706.464	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	282.87M
Price to Earnings Ratio	-3.38
Price to Sales Ratio	9.58
Price to Cash Ratio	7.5
Price to Book Ratio	1.9
Dividend Yield	-

Share Statistics

Shares Outstanding	71.43M
Average Volume (1 week)	18.92M
Average Volume (1 Month)	5.85M
52 Week Change	379.55%
52 Week High	5.17
52 Week Low	0.77

More Ratios Coming Soon!

Aclaris Therapeutics

Nexus Infrastructure

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions